IgG4-related disease Market The IgG4-Related Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage IgG4-Related Disease pipeline products will significantly revolutionize the IgG4-Related Disease market dynamics. The … Continue reading →

Colorectal Cancer Clinical Trial Colorectal Cancer companies are Nektar Therapeutics, ALX Oncology Inc., Processa Pharmaceuticals, Guojian Pharmaceutical, Gritstone Bio, Inc., Daiichi Sankyo, Novartis Pharmaceuticals, Shanghai Henlius Biotech, Sumitomo Pharma Oncology, Purple Biotech Ltd., Amgen, Mirati Therapeutics, Plus Therapeutics, Sparrow Pharmaceuticals, … Continue reading →

Triple Negative Breast Cancer Clinical Trial Emerging TNBC therapies include TECENTRIQ (Hoffmann-La Roche), IPI-549 (Infinity Pharmaceuticals), Leronlimab (CytoDyn), MDNA11 (Medicenna Therapeutics), VIP236 (Vincerx Pharma), and CFI-400945 (Treadwell Therapeutics) – are poised to significantly influence market expansion and transform the overall … Continue reading →

Obesity Clinical Trial Obesity Companies are Pfizer, Biolingus, Regor Pharmaceuticals, Zealand Pharma, Sirnaomics, Innovent Biologics, PegBio, NodThera Limited, Sciwind Biosciences, Boehringer Ingelheim, Clearmind Medicine, Sparrow Pharmaceuticals, Genexine, TransThera, Fractyl Health, Shionogi, and others. (Albany, USA) According to DelveInsight’s analysis, over … Continue reading →

Focal Segmental Glomerulosclerosis Market Focal Segmental Glomerulosclerosis Companies are Travere Therapeutics, Dimerix, Goldfinch Bio, Vertex Pharmaceuticals, GlaxoSmithKline, Dimerix Bioscience Pty Ltd, ChemoCentryx, AstraZeneca, Genentech, Inc., Sanofi, Mallinckrodt ARD LLC, ACELYRIN Inc., Kyowa Kirin Co., Ltd., Bristol-Myers Squibb, and others. Focal … Continue reading →